BioCentury
ARTICLE | Clinical News

Differin adapalene gel 0 regulatory update

June 25, 2007 7:00 AM UTC

FDA approved an NDA for Differin adapalene topical gel 0.3% to treat moderate to moderately severe acne. The company already markets a 0.1% formulation of the topical retinoid in the U.S. to treat acn...